The Anti-Cancer Drug, Doxorubicin, Causes Oxidant Stress-Induced Endothelial Dysfunction

Author(s)

Matthew B. Wolf, University of South Carolina - ColumbiaFollow
John W. Baynes, University of South Carolina - ColumbiaFollow

Document Type

Article

Subject Area(s)

Life Sciences, Biochemistry, Biophysics

Digital Object Identifier (DOI)

https://doi.org/10.1016/j.bbagen.2005.10.012

Publication Info

Published in Biochimica et Biophysica Acta, Volume 1760, Issue 2, 2005, pages 267-271.

© Biochimica et Biophysica Acta 2005, Elsevier.

APA Citation

Wolf, M., & Baynes, J. (2005). The Anti-Cancer Drug, Doxorubicin, Causes Oxidant Stress-Induced Endothelial Dysfunction. Biochimica et Biophysica Acta, 1760(2), 267–271. https://doi.org/10.1016/j.bbagen.2005.10.012

Rights

© Biochimica et Biophysica Acta 2005, Elsevier.